PharmEasy
India's largest online pharmacy and healthcare delivery platform
Signal history
2 totalPharmEasy expands diagnostic services to 17 Indian cities, increasing accessibility and affordability for a wider population.
PharmEasy Expands Diagnostic Services to 17 Indian Cities
PharmEasy has expanded its diagnostic test services to 17 cities across India, including major metropolitan areas and tier-2 cities. This expansion aims to increase accessibility and affordability of diagnostic services for a wider population, reinforcing PharmEasy's position as a comprehensive online healthcare aggregator.
This article synthesizes expert opinions and research on the potential impact of AI on the job market and the future of work.
PharmEasy Introduces 24/7 Online Doctor Consultations to Expand Digital Health Services
PharmEasy has launched 24/7 online doctor consultations, integrating telemedicine with its existing medicine delivery and diagnostics services to expand its digital health offerings. This move aims to create a seamless healthcare experience and capture a larger share of the patient journey in the competitive Indian healthtech market.
Key Changes (30d)
PharmEasy expands diagnostic services to 17 Indian cities, increasing accessibility and affordability for a wider population.
PharmEasy Expands Diagnostic Services to 17 Indian Cities
This article synthesizes expert opinions and research on the potential impact of AI on the job market and the future of work.
PharmEasy Introduces 24/7 Online Doctor Consultations to Expand Digital Health Services
Source Language Distribution
Language distribution will appear as more signals are collected from diverse sources.
Strategic themes and signal pattern
Strategic Themes
Recent Signal Pattern
Industry Peer Comparison
Why this company matters
PharmEasy is digitizing India's fragmented pharmacy and diagnostics market, creating infrastructure that could transform healthcare access for 1.4 billion people.
- Key domain relevance: Online Pharmacy, Diagnostics, Telemedicine
- Active monitoring with 2 signals in the last 30 days across 3 tracked sources.
Channel Context
PharmEasy is a key company within the Healthtech & Biotech channel. Its official updates regularly contribute to how users track developments in this space.
View channelMarket Context
PharmEasy operates in a global market where SigFact tracks official signals from primary sources.
See recent signals in this marketPeers and related companies
All companiesAstellas Pharma
Adv. marketMajor Japanese pharma company focused on urology, oncology, and transplantation
AstraZeneca
Anglo-Swedish pharma company with strong oncology and rare disease pipeline
BeiGene
Adv. marketChina's largest global biotech company focused on innovative oncology medicines
Biocon
India's largest biopharmaceutical company and global biosimilars leader
Biofourmis
Digital therapeutics and remote patient monitoring platform
CSL Limited
Global biotech leader in plasma-derived therapies and vaccines
Continue monitoring PharmEasy
Follow this company, add it to your watchlist, or explore its signal stream to stay informed.